Wednesday Morning Headlines

Here is what I am reading this morning: Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It (Forbes) – Highly recommended read! 23andMe is raising up to $300M on top of what they have already raised, valuing them at $2.5B (PitchBook). Venture capital firms invested more than $738 million in Medtech … Continue reading Wednesday Morning Headlines

Wednesday Reads

I am off to Minneapolis this afternoon for the Medtech Conference tomorrow.  Here is what I will be reading on the flight: Thousands of large-scale RNA sequencing experiments yield a comprehensive new human gene list and reveal extensive transcriptional noise How Accurate Is Direct-To-Consumer Genetic Testing? From Gold(ish) To Garbage What can AI bring to … Continue reading Wednesday Reads

What I’m Reading Today

Welcome to the work week.  Here are some good reads to help you get started: CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it All of Us aims to compile health … Continue reading What I’m Reading Today